Ares inherited Alcami via acquisition of American Capital
~8 parties said to move forward in second round
Pharma-services firm expected to trade for >12x Ebitda
Alcami, whose outsourced drug-development services help pharma and biotech companies more quickly bring new products to market, is in the midst of a sales process, Buyouts has learned. William Blair is conducting the auction for the contract development and manufacturing ...